Related Experiment Video
Updated: Jun 14, 2026

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
Published on: February 27, 2018
[Factors associated with mortality in cryptococcal meningitis]
Ji-qin Wu1, Bin Xu, Xue-ting Ou
1Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China.
Objective:
To investigate factors associated with mortality in non-AIDS patients with cryptococcal meningitis.
Methods:
We retrospectively reviewed 154 cases of non-HIV cryptococcal meningitis in a tertiary care hospital in China, from 1997 through 2007.
Results:
The 1-year attributable mortality was 19.6% (28/143), and overall mortality was 28.7% (41/143). Advanced age (> or = 60 years), delay in diagnosis (> 4 months), hematologic malignancy, solid malignancy, altered mental status (coma, seizure, herniation), and CSF drainage or shunting were factors associated with increased death; factors associated with increased survival were amphotericin B based initial therapy and flucytosine containing therapy. In multivariate analysis, age > or = 60 years, the time from symptom onset to diagnosis > 4 months, coma, cerebral herniation, and non-amphotericin B based initial therapy were independently associated with increased overall mortality; factors independently associated with cause-specific mortality were time from symptom onset to diagnosis > 4 months, cerebral herniation and non-amphotericin B based initial therapy.
Conclusion:
A variety of factors were associated with mortality in non-AIDS cryptococcal meningitis. Amphotericin B based initial treatment was independently correlated to improved 1-year survival.
Insights
Mortality in non-AIDS cryptococcal meningitis is linked to older age, delayed diagnosis, and severe symptoms. Initial treatment with amphotericin B significantly improves survival rates in these patients.
Area of Science:
- Infectious Diseases
- Neurology
- Critical Care Medicine
Context:
- Cryptococcal meningitis (CM) is a serious fungal infection, particularly in non-AIDS patients.
- Mortality rates for non-AIDS CM remain significant, necessitating identification of key prognostic factors.
- Understanding these factors is crucial for improving patient outcomes in this vulnerable population.
Purpose:
- To identify clinical and demographic factors associated with mortality in non-AIDS patients diagnosed with cryptococcal meningitis.
- To evaluate the impact of diagnostic delays and specific therapeutic interventions on survival.
- To determine independent predictors of both overall and cause-specific mortality.
Summary:
- A retrospective review of 154 non-HIV CM cases identified advanced age (≥60 years), delayed diagnosis (>4 months), hematologic/solid malignancies, altered mental status (coma, herniation), and CSF drainage as mortality predictors.
- Amphotericin B-based initial therapy and flucytosine-containing regimens were associated with increased survival.
- Multivariate analysis confirmed age, diagnostic delay, coma, cerebral herniation, and non-amphotericin B therapy as independent predictors of mortality.
Impact:
- Findings highlight the importance of timely diagnosis and aggressive management, including amphotericin B-based therapy, for non-AIDS CM patients.
- Identifies high-risk patient groups (elderly, those with malignancies or neurological deficits) requiring closer monitoring.
- Contributes to evidence-based guidelines for managing cryptococcal meningitis in immunocompetent individuals.
Related Concept Videos
Cryptococcal Meningitis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
